Literature DB >> 170053

Antibacterial Drugs today: II.

A P Ball, J A Gray, J M Murdoch.   

Abstract

Since the development of the sulphonamides in the 1930s and the subsequent development of antibiotics from the 1940s onwards, there have now been many drugs developed which are capable of chemotherapeutic activity in a patient infected by a susceptible micro-organism. This review is concerned with precise descriptions of important groups of antimicrobial drugs, with emphasis being placed on the more recently developed drugs. With each group of drugs the pharmacology, major therapeutic indications, dosages and adverse reactions are discussed. Part II of the review discusses the cephalosporins, polymyxins and aminoglycosides. The place of each in therapy is defined.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170053     DOI: 10.2165/00003495-197510020-00001

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  84 in total

Review 1.  The polymyxins.

Authors:  P D Hoeprich
Journal:  Med Clin North Am       Date:  1970-09       Impact factor: 5.456

2.  Nomogram for kanamycin dosage.

Authors:  G E Mawer; S B Lucas; J G McGough
Journal:  Lancet       Date:  1972-07-01       Impact factor: 79.321

3.  Kanamycin in urinary tract infections.

Authors:  R G Petersdorf; M Turck
Journal:  Ann N Y Acad Sci       Date:  1966-06-14       Impact factor: 5.691

4.  Gentamicin in the management of thermal injuries.

Authors:  B G MacMillan
Journal:  J Infect Dis       Date:  1969 Apr-May       Impact factor: 5.226

5.  Ototoxicity of gentamicin.

Authors:  J Wersäll; P G Lundquist; B Björkroth
Journal:  J Infect Dis       Date:  1969 Apr-May       Impact factor: 5.226

6.  Reissner's membrane after Kanamycin administration.

Authors:  Y Kaneko; T Nakagawa; K Tanaka
Journal:  Arch Otolaryngol       Date:  1970-11

7.  Resistance of gram-negative bacilli to gentamicin.

Authors:  C F Snelling; A R Ronald; C Y Cates; W C Forsythe
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

8.  Comparative activity of sisomicin, gentamicin, kanamycin, and tobramycin.

Authors:  J A Waitz; E L Moss; C G Drube; M J Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

9.  In vitro activity of tobramycin and gentamicin.

Authors:  M R Britt; R A Garibaldi; J N Wilfert; C B Smith
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

View more
  2 in total

1.  [Microbial sensitivity spectrum of framycetin. Comparison with the 1972 to 1993 resistance status].

Authors:  H Knothe; W Hauke
Journal:  Unfallchirurgie       Date:  1995-02

2.  Light-Emitting-Diode-Assisted, Fungal-Pigment-Mediated Biosynthesis of Silver Nanoparticles and Their Antibacterial Activity.

Authors:  Nobchulee Nuanaon; Sharad Bhatnagar; Tatsuya Motoike; Hideki Aoyagi
Journal:  Polymers (Basel)       Date:  2022-08-01       Impact factor: 4.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.